共 50 条
- [3] Therapeutic drug monitoring of biologics in psoriasis BIOLOGICS-TARGETS & THERAPY, 2019, 13 : 127 - 132
- [7] Optimising the Therapeutic Interval for Biologics in Patients with Psoriasis LIFE-BASEL, 2022, 12 (12):
- [8] Serum interleukin-22 and vascular endothelial growth factor serve as sensitive biomarkers but not as predictors of therapeutic response to biologics in patients with psoriasis JOURNAL OF DERMATOLOGY, 2013, 40 (10): : 805 - 812